ACTH Stimulation Test (for CAH) at Chughtai Lab

Understanding the ACTH Stimulation Test (for CAH) at Chughtai Lab

The ACTH Stimulation Test (for CAH) is a highly specialized dynamic endocrine investigation designed to evaluate the functional capacity of the adrenal glands and identify specific enzymatic blocks along the steroidogenesis pathway. Congenital Adrenal Hyperplasia (CAH) comprises a group of autosomal recessive disorders characterized by deficiencies in enzymes required for cortisol synthesis. The most common form, accounting for over 90% of cases, is 21-hydroxylase deficiency, which is caused by mutations in the CYP21A2 gene. Other rarer forms include 11-beta-hydroxylase deficiency and 3-beta-hydroxysteroid dehydrogenase deficiency. When cortisol production is impaired, the negative feedback loop regulating the hypothalamus and anterior pituitary gland is disrupted. This leads to persistent hypersecretion of Adrenocorticotropic Hormone (ACTH). The chronic elevation of ACTH overstimulates the adrenal cortex, causing glandular hyperplasia and the accumulation of cortisol precursors, which are subsequently shunted into the androgen synthesis pathway.

At Chughtai Lab, the ACTH Stimulation Test (for CAH) serves as the gold standard diagnostic tool for confirming or ruling out non-classic (late-onset) Congenital Adrenal Hyperplasia (NCCAH), as well as evaluating borderline cases of classic CAH. The test works by introducing a synthetic form of ACTH, known as cosyntropin or tetracosactide, into the patient’s bloodstream. This synthetic hormone acts directly on the melanocortin 2 receptors (MC2R) in the zona fasciculata of the adrenal cortex, stimulating the immediate synthesis and release of cortisol and its precursor molecules, primarily 17-hydroxyprogesterone (17-OHP). By measuring the baseline and post-stimulation levels of these hormones at precise intervals, clinical biochemists and endocrinologists can pinpoint the exact location of the enzymatic block. This dynamic evaluation is crucial because random, single-point measurements of 17-OHP can often fall into an indeterminate range, particularly in mild or non-classic forms of the disease. The diagnostic value of this test lies in its ability to unmask subclinical adrenal enzyme deficiencies under maximal stimulatory conditions, providing definitive clarity for patient management.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the clinical validity and accuracy of the ACTH Stimulation Test (for CAH). Because hormone levels fluctuate naturally and are influenced by external factors, patients must strictly adhere to the following preparation guidelines:

• Fasting Requirements: Patients are generally advised to fast overnight or for at least 8 hours prior to the test. Water is permitted, but caffeine, tea, and sugary beverages must be avoided.
• Timing of the Test: The test must be scheduled and initiated in the early morning, ideally around 8:00 AM. This timing aligns with the peak of the physiological diurnal rhythm of cortisol and ACTH secretion, establishing a standardized baseline.
• Menstrual Cycle Scheduling: For post-pubertal and adult females, the test should ideally be performed during the early follicular phase of the menstrual cycle (typically days 2 to 5). This timing is critical because 17-hydroxyprogesterone levels rise naturally during the luteal phase, which can lead to false-positive results.
• Medication Management: Patients must inform their healthcare provider of all medications, especially topical, oral, inhaled, or injected glucocorticoids (such as hydrocortisone, prednisone, or dexamethasone). These substances can suppress the hypothalamic-pituitary-adrenal (HPA) axis and alter test outcomes. Under medical supervision, short-acting glucocorticoids are typically withheld for at least 24 to 48 hours prior to testing.
• Stress Reduction: Physical and emotional stress can artificially elevate baseline cortisol and precursor levels. Patients should rest quietly before the procedure begins.

During the Procedure

The ACTH Stimulation Test (for CAH) is conducted in a controlled, comfortable clinical environment at Chughtai Lab by experienced phlebotomists and nursing staff. The step-by-step procedure is designed to ensure patient safety and precise timing:

• Intravenous Access: A qualified healthcare professional will insert an intravenous (IV) cannula into a vein in the patient’s arm. This cannula remains in place throughout the procedure to allow for multiple blood draws without the discomfort of repeated needle punctures.
• Baseline Blood Draw (T=0): The first blood sample is drawn to establish baseline levels of 17-hydroxyprogesterone (17-OHP), cortisol, and sometimes other androgens such as androstenedione and DHEA-S.
• ACTH Administration: Immediately after the baseline draw, a precise dose of synthetic ACTH (typically 250 micrograms for adults and older children, or a weight-adjusted dose for infants) is administered intravenously or intramuscularly.
• Timed Blood Draws: Blood samples are collected at specific intervals post-injection, most commonly at 30 minutes (T=30) and 60 minutes (T=60). These precise intervals capture the peak response of the adrenal cortex to the stimulatory hormone.
• Patient Experience and Safety: The procedure is generally well-tolerated. Some patients may experience mild, transient side effects immediately following the ACTH injection, such as a warm flushing sensation, mild nausea, or a metallic taste in the mouth. These symptoms typically resolve within a few minutes. Medical staff monitor the patient closely throughout the test, which takes approximately one to one and a half hours to complete.

When is an ACTH Stimulation Test (for CAH) Performed?

Evaluating Suspected Non-Classic Congenital Adrenal Hyperplasia (NCCAH)

Non-classic Congenital Adrenal Hyperplasia is a milder, late-onset form of the disease that may not present symptoms until adolescence or young adulthood. Physicians request the ACTH Stimulation Test when patients present with signs of androgen excess but have normal or borderline baseline 17-hydroxyprogesterone levels. The test assists in diagnosis by demonstrating an exaggerated accumulation of 17-OHP after ACTH stimulation, confirming a partial 21-hydroxylase deficiency.

Investigating Hyperandrogenism and Hirsutism in Females

Females presenting with severe hirsutism (excessive male-pattern hair growth), persistent cystic acne, and premature balding require comprehensive endocrine evaluation. Because these symptoms overlap significantly with Polycystic Ovary Syndrome (PCOS), the ACTH Stimulation Test is performed to differentiate PCOS from late-onset CAH. A marked rise in 17-OHP post-stimulation points directly to CAH, whereas a normal response helps rule it out, guiding appropriate therapeutic interventions.

Assessing Premature Adrenarche in Children

Premature adrenarche refers to the early appearance of pubic or axillary hair, body odor, and rapid bone maturation in girls under 8 years of age and boys under 9 years of age. Pediatric endocrinologists order the ACTH Stimulation Test to determine if early adrenal activation is due to a mild form of CAH. Identifying the condition early prevents premature epiphyseal fusion in long bones, which can lead to short adult stature.

Investigating Unexplained Infertility and Menstrual Irregularities

Chronic oligomenorrhea, amenorrhea, and unexplained infertility in women can be driven by underlying adrenal steroidogenesis defects. Elevated adrenal androgens disrupt the hypothalamic-pituitary-ovarian axis, impairing normal follicular development and ovulation. The ACTH Stimulation Test is utilized to identify subclinical CAH as the root cause of reproductive dysfunction, allowing for targeted glucocorticoid therapy to restore fertility.

Confirming Borderline Newborn Screening Results

Many modern neonatal screening programs measure 17-OHP via heel-prick blood spots to detect classic CAH. However, false positives are common, especially in premature or stressed infants. When newborn screening yields borderline or mildly elevated results, the ACTH Stimulation Test is performed as a definitive diagnostic step to confirm or rule out classic salt-wasting or simple virilizing CAH, ensuring life-saving treatment is initiated promptly if needed.

What Does an ACTH Stimulation Test (for CAH) Detect?

The ACTH Stimulation Test (for CAH) is capable of detecting and differentiating a wide spectrum of adrenal disorders and enzymatic abnormalities. Specifically, the test can identify:

• Classic 21-Hydroxylase Deficiency (Salt-Wasting form)
• Classic 21-Hydroxylase Deficiency (Simple Virilizing form)
• Non-Classic (Late-Onset) 21-Hydroxylase Deficiency
• 11-Beta-Hydroxylase Deficiency (characterized by elevated 11-deoxycortisol)
• 3-Beta-Hydroxysteroid Dehydrogenase Deficiency
• Normal Adrenal Cortical Reserve and steroid pathways
• Primary Adrenal Insufficiency (Addison’s Disease)
• Secondary Adrenal Insufficiency (due to pituitary dysfunction)
• Tertiary Adrenal Insufficiency (due to hypothalamic suppression)
• Exaggerated 17-Hydroxyprogesterone (17-OHP) response
• Blunted or flat Cortisol response to stimulation
• Elevated baseline and post-stimulation Androstenedione levels
• Elevated Dehydroepiandrosterone (DHEA) response
• Impaired cortisol synthesis pathway efficiency
• Severity of adrenal enzyme blockages
• Carrier status for CAH genetic mutations (often presenting with mild elevations)
• Exogenous steroid-induced adrenal suppression
• Functional adrenal androgen excess
• Adrenal hyperplasia secondary to chronic endogenous ACTH stimulation
• Aldosterone synthesis defects (when evaluated alongside aldosterone and renin)

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing accurate and timely diagnostic results. Because the ACTH Stimulation Test (for CAH) involves multiple timed blood samples and specialized chemiluminescent immunoassay (CLIA) or liquid chromatography-mass spectrometry (LC-MS) techniques, the analysis is performed under strict quality control protocols. Reports are typically finalized within 24 to 48 hours after sample collection. Patients receive automated SMS notifications as soon as their results are ready. Reports can be accessed online through the official Chughtai Lab website, via the Chughtai Lab mobile application, or collected in person from any of the numerous Chughtai Lab collection centers located across Pakistan.

ACTH Stimulation Test (for CAH) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Baseline 17-OHP	Less than 200 ng/dL (6 nmol/L)	Significantly elevated in classic CAH; mildly elevated in non-classic CAH.
Post-Stimulation 17-OHP (30/60 mins)	Less than 1000 ng/dL (30 nmol/L)	Greater than 1500 ng/dL (often >10,000 ng/dL in classic; 1500-10,000 ng/dL in non-classic CAH).
Baseline Cortisol	5 to 23 mcg/dL (morning peak)	Low or near-zero in classic salt-wasting CAH; normal to low in non-classic CAH.
Post-Stimulation Cortisol	Greater than 18-20 mcg/dL	Blunted or flat response (failure to rise) indicating adrenal insufficiency or severe block.
Baseline 11-Deoxycortisol	Less than 100 ng/dL	Markedly elevated in 11-beta-hydroxylase deficiency.
Post-Stimulation 11-Deoxycortisol	Minimal rise	Exaggerated rise confirming 11-beta-hydroxylase deficiency.
Androstenedione Response	Moderate, proportional rise	Exaggerated response contributing to hyperandrogenism and virilization.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for ACTH Stimulation Test (for CAH)?

• Experienced Healthcare Professionals: Our clinical biochemists, pathologists, and phlebotomists are highly trained in managing complex dynamic endocrine testing protocols.
• Patient-Focused Care: We prioritize patient comfort and safety, providing a dedicated, stress-free environment for multi-step testing procedures.
• Quality Diagnostic Services: Chughtai Lab utilizes advanced diagnostic technologies and adheres to strict international quality control standards.
• Professional Reporting: Accurate, clear, and comprehensive reports detailing baseline and post-stimulation values for precise clinical interpretation.
• Modern Diagnostic Approach: State-of-the-art laboratory equipment ensures high sensitivity and specificity for specialized hormone assays.
• Comfortable Environment: Our diagnostic centers are designed to offer a welcoming and professional atmosphere for patients of all ages.
• Convenient Location: With a vast network of collection centers across Pakistan, finding a Chughtai Lab facility near you is simple and convenient.
• Commitment to Accurate Diagnosis: We understand the critical nature of endocrine testing and are dedicated to delivering results you and your physician can trust.